title: The use of live attenuated influenza vaccine (LAIV) in healthcare personnel (HCP): guidance from the Society for Healthcare Epidemiology of America (SHEA).
abstract: Because of the live viral backbone of live attenuated influenza vaccine (LAIV), questions have arisen regarding infection control precautions and restrictions surrounding its use in healthcare personnel (HCP). This document provides guidance from the Society for Healthcare Epidemiology of America regarding use of LAIV in HCP and the infection control precautions that are recommended with its use in this population.
authors.affiliation: Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA. tom.talbot@vanderbilt.edu
authors.forename: Thomas R
authors.initials: TR
authors.lastname: Talbot
authors.forename: Hilary
authors.initials: H
authors.lastname: Babcock
authors.forename: Deborah
authors.initials: D
authors.lastname: Cotton
authors.forename: Lisa L
authors.initials: LL
authors.lastname: Maragakis
authors.forename: Gregory A
authors.initials: GA
authors.lastname: Poland
authors.forename: Edward J
authors.initials: EJ
authors.lastname: Septimus
authors.forename: Michael L
authors.initials: ML
authors.lastname: Tapper
authors.forename: David J
authors.initials: DJ
authors.lastname: Weber
mesh_terms: D006282:Health Personnel; D006801:Humans; D017053:Infection Control / Q000379:methods; D009980:Influenza A virus / Q000276:immunology*; D009981:Influenza B virus / Q000276:immunology*; D007252:Influenza Vaccines / Q000627:therapeutic use*; D007251:Influenza, Human / Q000517:prevention & control* / Q000821:virology; D017410:Practice Guidelines as Topic; D014481:United States; D014613:Vaccines, Attenuated / Q000627:therapeutic use; D017201:Virus Shedding
chemical_list: D007252:Influenza Vaccines; D014613:Vaccines, Attenuated